Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 712.95 T ARS | 14,775.000 ARS | −0.84% | 11.06 K | 0.93 | 118.34 | 124.85 ARS | +564.33% | 0.48% | Health technology | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 712.95 T ARS | 13.800 USD | −3.16% | 1.23 K | 1.49 | 107.10 | 124.85 ARS | +178.70% | 0.48% | Health technology | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 375.09 T ARS | 11,475.000 ARS | −0.86% | 13.7 K | 1.32 | 37.39 | 306.92 ARS | +257.75% | 1.39% | Health technology | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 375.09 T ARS | 1,340.000 ARS | 0.00% | 2 | 0.00 | — | — | — | — | Health technology | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 375.09 T ARS | 10.800 USD | −0.92% | 6.25 K | 2.69 | 34.10 | 306.92 ARS | +50.08% | 1.39% | Health technology | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 313.95 T ARS | 19,650.000 ARS | +2.75% | 1.82 K | 0.51 | 8.39 | 2,343.37 ARS | +183.01% | 1.79% | Health technology | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 313.95 T ARS | 18.300 USD | −0.81% | 84 | 0.41 | 7.57 | 2,343.37 ARS | +18.73% | 1.79% | Health technology | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 251.9 T ARS | 22,175.000 ARS | 0.00% | 2.37 K | 1.91 | 25.10 | 883.37 ARS | +899.22% | 1.56% | Health technology | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 251.9 T ARS | 22.000 USD | +3.53% | 15 | 0.31 | 24.13 | 883.37 ARS | +319.19% | 1.56% | Health technology | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 210.04 T ARS | 28,950.000 ARS | +0.70% | 612 | 3.88 | 3.34 | 8,672.72 ARS | +474.20% | 3.52% | Health technology | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 205.19 T ARS | 36,475.000 ARS | +2.60% | 5.35 K | 2.94 | 53.81 | 677.80 ARS | +291.99% | 1.57% | Health technology | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 205.19 T ARS | 34.600 USD | 0.00% | 10 | 0.60 | 49.46 | 677.80 ARS | +64.44% | 1.57% | Health technology | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 145.94 T ARS | 7,110.000 ARS | +2.60% | 24.57 K | 0.79 | 30.29 | 234.71 ARS | +224.10% | 3.54% | Health technology | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 145.94 T ARS | 6.670 USD | +2.46% | 8.43 K | 1.51 | 27.54 | 234.71 ARS | +35.96% | 3.54% | Health technology | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119.88 T ARS | 21,625.000 ARS | +0.12% | 742 | 0.59 | — | −1,078.84 ARS | −466.33% | 2.14% | Health technology | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119.88 T ARS | 21.000 USD | 0.00% | 2 | 0.04 | — | −1,078.84 ARS | −253.68% | 2.14% | Health technology | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 69.17 T ARS | 9,450.000 ARS | +0.96% | 2.63 K | 2.73 | 30.70 | 307.84 ARS | +49.45% | 2.76% | Health technology | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 69.17 T ARS | 8.800 USD | +0.57% | 8 | 0.48 | 27.70 | 307.84 ARS | −37.30% | 2.76% | Health technology | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 23.1 T ARS | 13,500.000 ARS | 0.00% | 898 | 0.97 | 19.41 | 695.64 ARS | +368.68% | 0.00% | Health technology | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 23.1 T ARS | 13.350 USD | +5.12% | 13 | 0.47 | 18.60 | 695.64 ARS | +96.62% | 0.00% | Health technology | — |
RICHLABORATORIOS RICHMOND SACIF | 150.2 B ARS | 1,860.000 ARS | +1.36% | 16.55 K | 0.69 | 840.11 | 2.21 ARS | — | 0.00% | Health technology | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5.02 B ARS | 118.000 ARS | +1.94% | 19.64 K | 3.36 | 7.26 | 16.26 ARS | — | 0.00% | Health technology | — |